Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, Y.
Right arrow Articles by Engelhardt, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, Y.
Right arrow Articles by Engelhardt, M.

Stem Cells 2003;21:15-20 www.StemCells.com
© 2003 AlphaMed Press


CONCISE REVIEW

CD34- Hematopoietic Stem Cells: Current Concepts and Controversies

Yalin Guo, Michael Lübbert, Monika Engelhardt

Department of Hematology/Oncology, University of Freiburg Medical Center, Freiburg, Germany

Key Words. Hematopoietic stem cells (HSCs) • CD34+ • CD34- • SP cells

Monika Engelhardt, M.D., University of Freiburg Medical Center, Department of Hematology/Oncology, Hugstetterstr. 55, D-79106 Freiburg, Germany. Telephone: 49-761-270-3406; Fax: 49-761-270-3206; e-mail:
engelhardtm{at}mm11.ukl.uni-freiburg.de

Recent data have suggested that human CD34- hematopoietic stem cells (HSCs) exist, challenging the concept that HSCs necessarily and exclusively express the CD34 antigen. In mice, quiescent HSCs have been shown to be mostly CD34-, but as a consequence of 5-fluorouracil treatment or cytokine stimulation, differentiate into CD34+ cells. Of particular interest is a novel, specific marker to identify HSCs, namely the Hoechst dye efflux property, with which a distinct side population (SP) is identified. These SP cells are mostly CD34-, highly enriched for long-term repopulating cells, and durably engraft in sublethally irradiated non-obese diabetic/severe combined immunodeficient mice. Using a semiquantitative reverse transcription-polymerase chain reaction, one of the ATP-binding cassette (ABC) transporters, the breast cancer resistance protein (Bcrp) or ABC transporter G2 (ABCG2), was found to be highly expressed in SP cells as well as other primitive HSCs and to sharply drop with hematopoietic differentiation. Enforced expression of the ABCG2 cDNA resulted in a robust SP phenotype and a reduction in hematopoietic maturation. These data suggest that the Bcrp/ABCG2 gene contributes importantly to the generation of the SP phenotype, which allows for the selection of immature, pluripotent HSCs. The isolation of Bcrp/ABCG2+ cells appears to be an attractive tool to analyze and characterize HSCs, and may eventually allow for the purification of these cells for clinical purposes. In this review, current concepts on murine and human CD34- HSCs and their relationship with CD34+ HSCs are discussed.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
S. Meindl, U. Schmidt, C. Vaculik, and A. Elbe-Burger
Characterization, isolation, and differentiation of murine skin cells expressing hematopoietic stem cell markers
J. Leukoc. Biol., October 1, 2006; 80(4): 816 - 826.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J P A Samijn, P A W te Boekhorst, T Mondria, P A van Doorn, H Z Flach, F G A van der Meche, J Cornelissen, W C Hop, B Lowenberg, and R Q Hintzen
Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 46 - 50.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. G. W. Verhaak, C. S. Goudswaard, W. van Putten, M. A. Bijl, M. A. Sanders, W. Hugens, A. G. Uitterlinden, C. A. J. Erpelinck, R. Delwel, B. Lowenberg, et al.
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
Blood, December 1, 2005; 106(12): 3747 - 3754.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Leri, J. Kajstura, and P. Anversa
Cardiac Stem Cells and Mechanisms of Myocardial Regeneration
Physiol Rev, October 1, 2005; 85(4): 1373 - 1416.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. J. Huss, D. R. Gray, N. M. Greenberg, J. L. Mohler, and G. J. Smith
Breast Cancer Resistance Protein-Mediated Efflux of Androgen in Putative Benign and Malignant Prostate Stem Cells
Cancer Res., August 1, 2005; 65(15): 6640 - 6650.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Sosnova, M. Bradl, and J. V. Forrester
CD34+ Corneal Stromal Cells Are Bone Marrow-Derived and Express Hemopoietic Stem Cell Markers
Stem Cells, April 1, 2005; 23(4): 507 - 515.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Sergejeva, A.-K. Johansson, C. Malmhall, and J. Lotvall
Allergen exposure-induced differences in CD34+ cell phenotype: relationship to eosinophilopoietic responses in different compartments
Blood, February 15, 2004; 103(4): 1270 - 1277.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2003 by AlphaMed Press.